Prenatal Care Practice Questions

Q: How should a woman who had 4 pregnancies at term delivered, one of which is twin pregnancy, be designated?

Gravida 4 Para 4. ### Explanation The correct designation is **Gravida 4 Para 4**. This question tests the fundamental understanding of obstetric terminology, specifically the distinction between how pregnancies and births are counted. **1. Why Option B is Correct:** * **Gravida (G):** Refers to the total number of times a woman has been pregnant, regardless of the outcome or the number of fetuses. Since this woman had 4 pregnancies, she is **G4**. * **Para (P):** Refers to the number of pregnancies that have reached the age of viability (usually 20–24 weeks). Crucially, **multiple gestations (twins, triplets) count as a single parous event.** Even though she delivered five children, she had 4 delivery events that reached term. Therefore, she is **P4**. **2. Why the Other Options are Incorrect:** * **Option A (G4 P5):** Incorrectly counts the twin delivery as two parous events. Parity refers to the *pregnancy event*, not the number of infants born. * **Option C (G5 P4):** Incorrectly assumes the twin pregnancy counts as two pregnancies. A twin pregnancy is a single obstetric event. * **Option D (G5 P5):** Incorrectly counts both pregnancies and births based on the number of fetuses rather than the number of gestations. **3. NEET-PG High-Yield Clinical Pearls:** * **The "Event" Rule:** Always remember: **Gravida = Pregnancies; Para = Birth Events.** Twins = G1 P1. * **GTPAL System:** For more detailed coding: * **G** (Gravida): Total pregnancies. * **T** (Term): Deliveries >37 weeks. * **P** (Preterm): Deliveries 20–37 weeks. * **A** (Abortion): Loss <20 weeks. * **L** (Living): Number of living children (This is the *only* section where twins count as two). * **Nulligravida:** Never been pregnant. * **Primigravida:** Pregnant for the first time. * **Multipara:** Has completed two or more pregnancies to viability.

Q: A pregnant patient with G2P1L1 and twin gestation has a BMI of 26. What is the ideal weight gain recommended during pregnancy?

31-50 lb. The recommended weight gain during pregnancy is based on the pre-pregnancy Body Mass Index (BMI) and the number of fetuses. This question tests the specific guidelines for **twin gestations** as established by the Institute of Medicine (IOM). ### **Explanation of the Correct Answer** The patient has a BMI of 26, which classifies her as **Overweight** (BMI 25.0–29.9). According to IOM guidelines for twin pregnancies: * **Normal BMI (18.5–24.9):** 37–54 lb (16.8–24.5 kg) * **Overweight BMI (25.0–29.9):** **31–50 lb (14.1–22.7 kg)** * **Obese BMI (≥30):** 25–42 lb (11.3–19.1 kg) Since the patient falls into the overweight category, the ideal weight gain is **31–50 lb**. ### **Analysis of Incorrect Options** * **Option A (37-54 lb):** This is the recommended range for a woman with a **Normal pre-pregnancy BMI** carrying twins. * **Option C (25-42 lb):** This is the recommended range for an **Obese woman** (BMI ≥30) carrying twins. ### **NEET-PG High-Yield Pearls** 1. **Singleton Pregnancy Guidelines:** For a normal BMI (18.5–24.9), the recommended gain is **25–35 lb (11.5–16 kg)**. 2. **Underweight Patients:** Women with a BMI <18.5 should gain the most weight (28–40 lb for singletons; no specific IOM range for twins, but generally encouraged to exceed normal ranges). 3. **Weight Distribution:** In a singleton pregnancy, the fetus accounts for only about 25% of the total weight gain; the rest is due to the placenta, amniotic fluid, uterine hypertrophy, and increased blood volume. 4. **Clinical Significance:** Inadequate weight gain increases the risk of IUGR and preterm birth, while excessive gain increases the risk of gestational diabetes, preeclampsia, and macrosomia.

Q: A pregnant woman with recent onset of urinary frequency, urgency, dysuria, and evidence of bacteriuria should be treated with:

Cephalexin. ### Explanation **Correct Answer: D. Cephalexin** **Medical Concept:** The patient presents with symptoms of **Acute Cystitis** (frequency, urgency, dysuria, and bacteriuria). In pregnancy, even asymptomatic bacteriuria must be treated to prevent progression to pyelonephritis, which is associated with preterm labor and maternal sepsis. **Cephalexin (a first-generation cephalosporin)** is considered a first-line treatment because it is safe (FDA Category B), effective against common uropathogens like *E. coli*, and lacks the teratogenic risks associated with other antibiotics. **Analysis of Incorrect Options:** * **A & B (Ciprofloxacin and Norfloxacin):** These are Fluoroquinolones. They are generally **contraindicated** in pregnancy because they have a high affinity for bone and cartilage, potentially leading to **arthropathy** and permanent joint damage in the developing fetus. * **C (Trimethoprim-sulfamethoxazole):** This combination is usually avoided in the **first trimester** (Trimethoprim is a folate antagonist linked to neural tube defects) and the **third trimester** (Sulfonamides compete with bilirubin for albumin binding sites, increasing the risk of **kernicterus** in the newborn). **High-Yield Clinical Pearls for NEET-PG:** * **First-line agents for UTI in pregnancy:** Nitrofurantoin (avoid near term/at 36+ weeks due to risk of neonatal hemolysis), Amoxicillin-Clavulanate, and Cephalexin. * **Screening:** All pregnant women should be screened for asymptomatic bacteriuria at **12–16 weeks** gestation via urine culture. * **Definition of Bacteriuria:** $\geq 10^5$ colony-forming units (CFU)/mL of a single uropathogen in a midstream voided specimen. * **Drug of Choice for Pyelonephritis in pregnancy:** Intravenous Ceftriaxone.

Q: Which of the following vaccines is contraindicated in pregnancy?

Yellow fever. **Explanation:** The fundamental principle in prenatal vaccination is that **Live Attenuated Vaccines** are generally **contraindicated** during pregnancy. This is due to the theoretical risk of the live virus crossing the placenta and causing fetal infection or teratogenic effects. **Yellow Fever (Option C)** is a live attenuated viral vaccine. It is contraindicated in pregnancy unless the risk of exposure to the disease (e.g., travel to endemic areas where the risk of infection is high) outweighs the potential risk of vaccination. If a pregnant woman must travel to an endemic zone, the vaccine is administered, but it remains the "most contraindicated" among the options provided. **Why the other options are incorrect:** * **Rabies (Option A):** This is an **inactivated** vaccine. It is safe and indicated for post-exposure prophylaxis in pregnancy because the disease is 100% fatal. * **Hepatitis B (Option B):** This is a **recombinant/subunit** vaccine. It is safe and recommended for pregnant women at high risk of infection. * **Hepatitis A (Option A):** This is an **inactivated** vaccine. It can be administered if there is a high risk of exposure. **High-Yield Clinical Pearls for NEET-PG:** * **Absolute Contraindications (Live Vaccines):** MMR (Measles, Mumps, Rubella), Varicella, BCG, and Oral Polio (OPV). * **The "Rule of 1 Month":** Women should be advised to avoid pregnancy for at least 4 weeks after receiving a live vaccine (especially Rubella). * **Recommended Vaccines:** Tdap (Tetanus, Diphtheria, and acellular Pertussis) is recommended in every pregnancy (ideally between 27–36 weeks) to provide passive immunity to the neonate. * **Influenza:** The **inactivated** injectable flu vaccine is safe and recommended in any trimester during flu season. The intranasal flu vaccine is live and contraindicated.

Q: Nuchal Skin Fold thickness scan is typically performed between which gestational ages?

18-22 weeks. **Explanation:** The **Nuchal Skin Fold (NF)** thickness is a second-trimester ultrasound marker used to screen for chromosomal abnormalities, primarily Down Syndrome (Trisomy 21). **1. Why 18-22 weeks is correct:** The Nuchal Fold is measured during the **Anomaly Scan (Level II scan)**, typically between **18 and 22 weeks** of gestation. It is measured in the transcerebellar plane of the fetal head (axial view). A value of **≥ 6 mm** is considered thickened and is one of the most sensitive "soft markers" for Down Syndrome in the second trimester. **2. Analysis of Incorrect Options:** * **A & B (6-14 weeks):** These are too early for Nuchal *Fold* measurement. However, **11-14 weeks** is the specific window for measuring **Nuchal Translucency (NT)**. While both assess the neck area, NT measures the fluid-filled space behind the neck in the first trimester, whereas NF measures skin thickness in the second trimester. * **D (28-32 weeks):** By the third trimester, the Nuchal Fold measurement loses its diagnostic sensitivity and specificity for aneuploidy screening due to normal physiological changes in fetal soft tissue. **3. High-Yield Clinical Pearls for NEET-PG:** * **Nuchal Translucency (NT):** Measured at 11–13.6 weeks; abnormal if **> 3 mm** (associated with Trisomy 21 and Turner Syndrome). * **Nuchal Fold (NF):** Measured at 18–22 weeks; abnormal if **≥ 6 mm**. * **Most Sensitive Marker:** Among all second-trimester soft markers for Down Syndrome, a thickened Nuchal Fold has the highest likelihood ratio. * **Anatomical Landmarks for NF:** Cavum septum pellucidum, Cerebellum, and Cisterna magna.

Q: At what gestational age does fetal heart activity become detectable by Doppler ultrasound in pregnancy?

Before 16 weeks. ### Explanation **Correct Answer: A. Before 16 weeks** The fetal heart begins to beat at approximately 5.5 to 6 weeks of gestation. However, the timing of detection depends on the modality used: * **Transvaginal Ultrasound (TVS):** Detects cardiac activity as early as **5.5–6 weeks**. * **Transabdominal Ultrasound (TAS):** Detects activity by **7–8 weeks**. * **Handheld Doppler (Electronic):** Can typically detect fetal heart sounds between **10 and 12 weeks** of gestation. * **Pinard Stethoscope (Fetoscope):** Requires more advanced development and can detect sounds by **18–20 weeks**. Since a handheld Doppler can pick up the fetal heart rate as early as the late first trimester (10–12 weeks), "Before 16 weeks" is the most accurate clinical timeframe among the choices. **Why the other options are incorrect:** * **B & C (After 18/20 weeks):** These timeframes are associated with **fetoscopy** (clinical auscultation using a Pinard stethoscope), not Doppler ultrasound. Waiting until 18–20 weeks to confirm heart activity via Doppler would represent a significant clinical delay. * **D (After 24 weeks):** This is well into the second trimester and is far beyond the standard window for initial Doppler detection. **NEET-PG High-Yield Pearls:** * **First sign of pregnancy on USG:** Gestational sac (seen at ~4.5–5 weeks with TVS). * **Yolk sac:** Appears at ~5 weeks; its presence confirms an intrauterine pregnancy. * **Discriminatory Zone:** The level of serum β-hCG at which a gestational sac should be visible (typically **1500–2000 mIU/mL** for TVS). * **Fetal Heart Rate (FHR):** Starts at ~110 bpm in early pregnancy, peaks at ~170 bpm at 9 weeks, and stabilizes to **110–160 bpm** near term.

Q: Which of the following physiological changes is LEAST likely to occur during pregnancy?

A decrease in vital capacity.. **Explanation:** The correct answer is **D. A decrease in vital capacity.** In pregnancy, the diaphragm is displaced superiorly by approximately 4 cm due to the enlarging uterus. However, this is compensated for by an increase in the anteroposterior and transverse diameters of the thoracic cage (mediated by relaxin). Consequently, while the **Functional Residual Capacity (FRC)** and **Residual Volume (RV)** decrease, the **Vital Capacity (VC) remains unchanged** or may even show a slight increase. This is a high-yield distinction in maternal physiology. **Analysis of Incorrect Options:** * **Option A:** Pregnancy is a state of "hemodilution." While platelet production increases, the massive increase in plasma volume leads to a relative decrease in concentration, often resulting in **gestational thrombocytopenia** (platelets at the lower end of normal). * **Option B:** The **White Blood Cell (WBC) count increases** during pregnancy (physiologic leukocytosis), typically ranging from 5,000–12,000/mm³ and can rise up to 25,000/mm³ during labor. * **Option C:** Pregnancy is a **hypercoagulable state**. There is a marked increase in most clotting factors (especially VII, VIII, IX, X, and Fibrinogen) and a decrease in Protein S and fibrinolytic activity to prevent postpartum hemorrhage. **NEET-PG High-Yield Pearls:** * **Most common respiratory change:** Increase in **Tidal Volume** (by ~40%), leading to physiologic hyperventilation and respiratory alkalosis. * **Cardiac Output:** Increases by 30-50%, peaking at 28-32 weeks. * **Blood Volume:** Plasma volume increases (50%) more than RBC mass (20-30%), causing **physiologic anemia**.

Q: A 38-year-old primigravida, pregnant following IVF, has a sonogram at 12 weeks 4 days gestation showing a nuchal translucency of 5 mm. Which of the following is the only true statement?

The embryo has a high risk of cardiac malformation.. **Explanation:** **1. Why Option B is Correct:** Nuchal Translucency (NT) is the sonographic appearance of a collection of fluid under the skin behind the fetal neck in the first trimester (11 to 13+6 weeks). A measurement of **≥3.5 mm** is considered significantly increased. While NT is primarily used to screen for aneuploidies (like Down syndrome), an increased NT in a **euploid (chromosomally normal) fetus** is strongly associated with **congenital heart defects (CHDs)**, such as Tetralogy of Fallot or Septal defects. This is likely due to transient heart failure or altered hemodynamics during development. **2. Why the Other Options are Incorrect:** * **Option A:** Neural tube defects (NTDs) are associated with abnormal maternal serum alpha-fetoprotein (MSAFP) and specific second-trimester ultrasound findings (e.g., lemon sign, banana sign), not increased NT. * **Option C:** Increased NT usually **resolves** or evolves into a cystic hygroma or nuchal edema by the second trimester; it does not typically "enlarge" as a standard progression. * **Option D:** While Turner syndrome (45,X) is associated with very high NT/cystic hygroma, the **most common** aneuploidy associated with increased NT is **Trisomy 21 (Down syndrome)**. **Clinical Pearls for NEET-PG:** * **Ideal Timing for NT:** 11 weeks to 13 weeks 6 days (CRL 45–84 mm). * **Combined Screening:** NT + PAPP-A + hCG (Detection rate for Down syndrome ~85-90%). * **Next Step:** If NT is increased, the patient should be offered invasive testing (CVS/Amniocentesis) for karyotyping and a **Fetal Echocardiogram** at 18–22 weeks. * **IVF Pregnancy:** IVF itself is an independent risk factor for cardiac malformations, further increasing the relevance of this finding.

Q: What is the minimum recommended daily dosage of folic acid supplementation for women during the preconception period?

400 micrograms. **Explanation:** The correct answer is **400 micrograms (0.4 mg)**. Folic acid is a B-complex vitamin essential for DNA synthesis and amino acid metabolism. During the first few weeks of pregnancy—often before a woman knows she is pregnant—the neural tube closes. Adequate folate levels are critical to prevent **Neural Tube Defects (NTDs)** such as anencephaly and spina bifida. * **Why 400 mcg is correct:** International guidelines (WHO, FIGO) and national protocols (MoHFW, India) recommend a daily dose of 400 mcg starting at least **one month prior to conception** and continuing through the first trimester (12 weeks) to ensure optimal maternal serum and red cell folate levels. * **Why A, B, and C are incorrect:** 10, 40, and 100 micrograms are sub-therapeutic doses. They do not provide sufficient folate to significantly reduce the risk of NTDs in the general population. **High-Yield Clinical Pearls for NEET-PG:** 1. **High-Risk Dosage:** For women with a **previous history** of a child with an NTD, the recommended dose is increased tenfold to **4 mg (4000 mcg)** daily. 2. **Timing:** Supplementation must ideally begin **pre-conceptionally** because the neural tube closes by the **28th day** post-conception. 3. **Other High-Risk Groups:** Women with diabetes, those on anti-epileptic drugs (e.g., Valproate), or those with malabsorption syndromes also require higher doses (5 mg). 4. **Iron-Folic Acid (IFA) Tablet:** Under the *Anemia Mukt Bharat* guidelines, pregnant women are prescribed 60 mg elemental iron and 500 mcg folic acid daily for 180 days starting from the second trimester.

Question 1

How should a woman who had 4 pregnancies at term delivered, one of which is twin pregnancy, be designated?

Accepted Answer

Gravida 4 Para 4

Answer

Gravida 4 Para 5

Answer

Gravida 5 Para 4

Answer

Gravida 5 Para 5

Question 2

A 26-year-old G1, P0 presents to the OBGYN department with a complaint of moderate vaginal bleeding noticed while bathing. On examination, there are no uterine contractions, pain, or abdominal cramps. Vital signs are: Blood pressure 120/76 mmHg, Pulse rate 84/min, temperature 37.6°C, Respiratory rate 16/min. Speculum examination reveals a small clot at the vault, with no active bleeding or abnormal mass. The cervix is closed. Bimanual examination is unremarkable. What is the most likely diagnosis?

Accepted Answer

Threatened abortion

Answer

Missed abortion

Answer

Inevitable abortion

Answer

Incomplete abortion

Question 3

A pregnant patient with G2P1L1 and twin gestation has a BMI of 26. What is the ideal weight gain recommended during pregnancy?

Accepted Answer

31-50 lb

Answer

37-54 lb

Answer

25-42 lb

Answer

None of the above

Question 4

A pregnant woman with recent onset of urinary frequency, urgency, dysuria, and evidence of bacteriuria should be treated with:

Accepted Answer

Cephalexin

Answer

Ciprofloxacin

Answer

Norfloxacin

Answer

Trimethoprim-sulfamethoxazole

Question 5

Which of the following vaccines is contraindicated in pregnancy?

Accepted Answer

Yellow fever

Answer

Rabies

Answer

Hepatitis B

Answer

Hepatitis A

Question 6

Nuchal Skin Fold thickness scan is typically performed between which gestational ages?

Accepted Answer

18-22 weeks

Answer

6-10 weeks

Answer

11-14 weeks

Answer

28-32 weeks

Question 7

At what gestational age does fetal heart activity become detectable by Doppler ultrasound in pregnancy?

Accepted Answer

Before 16 weeks

Answer

After 18 weeks

Answer

After 20 weeks

Answer

After 24 weeks

Question 8

Which of the following physiological changes is LEAST likely to occur during pregnancy?

Accepted Answer

A decrease in vital capacity.

Answer

A reduction in platelet concentration to the lower end of the normal range.

Answer

An increase in the white blood cell count.

Answer

An increase in the levels of coagulation factors VII, VIII, and X.

Question 9

A 38-year-old primigravida, pregnant following IVF, has a sonogram at 12 weeks 4 days gestation showing a nuchal translucency of 5 mm. Which of the following is the only true statement?

Accepted Answer

The embryo has a high risk of cardiac malformation.

Answer

The embryo has a high risk of neural tube defect.

Answer

The nuchal translucency will enlarge by 20 weeks.

Answer

If the embryo is aneuploid, the most likely diagnosis is Turner syndrome.

Question 10

What is the minimum recommended daily dosage of folic acid supplementation for women during the preconception period?

Accepted Answer

400 micrograms

Answer

10 micrograms

Answer

40 micrograms

Answer

100 micrograms

Prenatal Care — MCQs

Prenatal Care — MCQs

On this page

Practice by Chapter

Want unlimited practice?